Leidos (NYSE: LDOS) director exercises stock options and updates holdings

Rhea-AI Filing Summary

Leidos Holdings director Noel B. Geer reported multiple stock option exercises. On March 4, 2026, he exercised options for 2,123, 1,769 and 2,296 shares of Leidos common stock, acquiring the same numbers of shares through derivative conversions. Following these transactions, he directly held 43,206.8435 Leidos shares, with additional indirect holdings of 2,000 shares by spouse and 32,000 shares by a family trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geer Noel B

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		M		2,123	A	$103.9	39,141.8435	D
Common Stock	03/04/2026		M		1,769	A	$104.06	40,910.8435	D
Common Stock	03/04/2026		M		2,296	A	$79.45	43,206.8435	D
Common Stock								2,000	I	By Spouse
Common Stock								32,000	I	by Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$103.9	03/04/2026		M			2,123	04/29/2022	05/06/2028	Common Stock	2,123	$0	0	D
Stock Option (Right to Buy)	$104.06	03/04/2026		M			1,769	04/28/2023	05/05/2029	Common Stock	1,769	$0	0	D
Stock Option (Right to Buy)	$79.45	03/04/2026		M			2,296	04/26/2024	05/04/2030	Common Stock	2,296	$0	0	D

Explanation of Responses:

Remarks:

	/s/ Ramune M. Kligys by PoA of Noel B. Geer	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Leidos (LDOS) director Noel B. Geer report?

Noel B. Geer reported exercising stock options into Leidos common shares. On March 4, 2026, he converted three blocks of stock options into common stock, reflecting derivative exercises rather than open-market purchases or sales.

How many Leidos (LDOS) stock options did Noel B. Geer exercise?

Noel B. Geer exercised three sets of stock options for 2,123, 1,769 and 2,296 shares. Each exercise converted stock options into an equal number of Leidos common shares under code M, which indicates an exercise or conversion of derivative securities.

What is Noel B. Geer’s direct Leidos (LDOS) shareholding after the Form 4 transactions?

After the reported transactions, Noel B. Geer directly held 43,206.8435 shares of Leidos common stock. This figure reflects his updated direct ownership following the March 4, 2026 stock option exercises and resulting acquisitions of common shares.

What indirect Leidos (LDOS) holdings are associated with Noel B. Geer?

Indirect holdings associated with Noel B. Geer include 2,000 Leidos shares held by his spouse and 32,000 shares held by a family trust. These positions are reported as indirect ownership, separate from his directly held common stock.

Did the Leidos (LDOS) Form 4 show any insider stock sales by Noel B. Geer?

The Form 4 shows no insider stock sales for Noel B. Geer. All recorded transactions with code M reflect the exercise or conversion of derivative securities into Leidos common stock, categorized as acquisitions rather than open-market disposals.